Plus the list of biosimilars approved by the FDA ... Widespread adoption of biosimilar drugs could multiply these savings across global healthcare systems, huge cost savings.

Thwarted in her ambition to become a brewmaster, Kiran Mazumdar-Shaw channeled her frustrations into building a knockoff drug ...

Chicago, IL – June 10, 2025 – Today, Zacks Equity Research discusses Sandoz SDZNY, Teva Pharmaceuticals TEVA and Viatris VTRS ...

Prescription drugs prices have rapidly increased, but opting for generic medications and incorporating lifestyle changes are some ways to cut costs.

President Donald J. Trump has signaled that lowering the costs of prescription drugs will be a priority for his second term.

Switching to Humira biosimilars saved Navitus clients more than $315 million in upfront costs in 2024 and resulted in a 60% ...

McKesson Corporation (NYSE:MCK) is one of the 11 Best Drug Stocks to Buy According to Hedge Funds. On June 11, analyst ...

Across brand drugs, pharmacy list prices are 422 percent higher in ... the patent thickets that slow to a crawl any generic and biosimilar competition from entering the market to compete with ...

Biosimilars marketed in the US typically have list prices 15% to 35% lower than ... sometimes force diabetics to ration their use of the drugs. Semglee's latest approval follows the publication ...